Improved survival outcome for hepatoblastoma based on an optimal chemotherapeutic regimen--a report from the study group for pediatric solid malignant tumors in the Kyushu area.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D004341:Drug Evaluation; D004621:Embolization, Therapeutic; D005260:Female; D006498:Hepatectomy; D018197:Hepatoblastoma / Q000188:drug therapy* / Q000401:mortality / Q000601:surgery / Q000628:therapy; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007564:Japan / Q000453:epidemiology; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000601:surgery / Q000628:therapy; D008297:Male; D009367:Neoplasm Staging; D012042:Registries; D012189:Retrospective Studies; D016019:Survival Analysis; D016896:Treatment Outcome